CT活检阴性结果的影像-病理对照可提高胸部恶性肿瘤的阴性预测值
该服务评价研究评估多学科团队(MDT)对非恶性肺活检结果进行影像-病理对照的实践,纳入2014年5月至2017年5月60例初诊CT活检非恶性患者,最终55例分析。影像-病理对照后阴性预测值从单独CT活检的80%提升至97%,且无患者从活检到切除期间发生分期改变。
要点
- 对CT活检非恶性结果进行影像-病理对照,可将阴性预测值从80%提高至97%。
- 影像与病理不一致的病灶中,最终9例为恶性,需重复活检或手术切除确认。
- 影像-病理对照未导致肺癌诊断延迟,无患者发生分期改变。
核心结论
- 结合影像-病理对照解读阴性活检结果可提高肺恶性肿瘤的阴性预测值,且不延迟肺癌诊断。
研究设计与样本
- 服务评价研究,评估MDT对非恶性肺活检结果的管理,时间范围为2014年5月至2017年5月;初始60例CT活检非恶性患者,5例失访,最终队列55例;参考标准为影像随访、重复活检或手术切除病理。
关键影像表现/征象
- 48例活检结果为潜在非特异性,其中26例与影像一致(如机化性肺炎伴相容CT特征),22例不一致(如非特异性炎症但CT特征足够可疑)。
- 影像-病理一致的阴性病例中,19例影像随访显示病灶消退,6例稳定;1例病灶增大并经手术切除证实为恶性。
- 影像-病理不一致的病灶接受重复活检(8例)或手术切除(13例),最终12例良性、9例恶性。
诊断标准与关键数值
- 单独CT活检的阴性预测值为44/55(80%)。
- 重复活检后的阴性预测值为44/50(88%)。
- 影像-病理评估后的阴性预测值为32/33(97%)。
临床应用与阅片要点
- 对CT活检非恶性结果应结合影像特征进行影像-病理对照,以识别可能假阴性的病灶。
- 影像与病理不一致的病灶可通过重复活检或手术切除进一步明确。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate multidisciplinary team (MDT) practice of radiological-pathological correlation of non-malignant biopsy results to examine the additive effect on the predictive values of computed tomography (CT) biopsy for malignancy and their subsequent management and outcomes.
MATERIALS AND METHODS: A service evaluation of the MDT management of non-malignant lung biopsy results (May 2014- May 2017) was undertaken.
RESULTS: Sixty patients had a non-malignant diagnosis on initial CT biopsy. Five patients were lost to follow-up leaving 55 in the final cohort. Forty-eight of the 55 patients had biopsy results classified as potentially non-specific, of which 26 were classified as concordant with radiology (e.g., organising pneumonia with compatible CT features), and 22 were classified as discordant (e.g., non-specific inflammation and yet sufficiently suspicious CT features). Patients with concordant negative pathology showed resolution (n=19) or stability (n=6) on imaging follow-up. One lesion demonstrated growth and was proven malignant on surgical resection. Discordant lesions were managed with repeat biopsy (n=8) or surgical resection (n=13), with 12 final benign diagnoses and nine malignancies. The negative predictive value of CT biopsy alone was 44/55 (80%), following repeat biopsy was 44/50 (88%), and following radiological-pathological assessment was 32/33 (97%). No patients underwent a shift in stage from time of biopsy to resection.
CONCLUSION: Combining radiological-pathological interpretation of negative biopsy results offers superior negative predictive value for lung malignancy without delayed diagnosis of lung cancer.
引用
- Barnett J, Pulzato I, Javed M, et al. Radiological-pathological correlation of negative CT biopsy results enables high negative predictive value for thoracic malignancy. Clin Radiol. 2020. PMID: 33059852. doi:10.1016/j.crad.2020.08.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。